Oppenheimer & Co »

Catalyst Pharmaceutical Partners shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 92k 19.70
2025-06-30 $2.2M 103k 21.70
2025-03-31 $2.4M 99k 24.25
2024-12-31 $2.2M 105k 20.87
2024-09-30 $1.6M 81k 19.88
2024-03-31 $806k 51k 15.94

More positions owned by Oppenheimer & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Servicetitan Shs Cl A (TTAN)

View all positions for Oppenheimer & Co

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners